Bioenergetics and metabolism: a bench to bedside perspective

被引:25
作者
Swerdlow, Russell H. [1 ,2 ,3 ,4 ]
机构
[1] Univ Kansas, Alzheimers Dis Ctr, Kansas City, KS USA
[2] Univ Kansas, Med Ctr, Dept Neurol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA
[3] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA
[4] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA
关键词
Alzheimer's disease; bioenergetics; metabolism; mitochondria; neurodegeneration; AMYLOID PRECURSOR PROTEIN; MITOCHONDRIAL CASCADE HYPOTHESIS; COMPLEX-I DEFICIENCY; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; PARKINSONS-DISEASE; CREATINE SUPPLEMENTATION; CYTOCHROME-OXIDASE; ENERGY-METABOLISM; SKELETAL-MUSCLE;
D O I
10.1111/jnc.13509
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolism' refers to the vast collection of chemical processes that occur within a living organism. Within this broad designation, one can identify metabolism events that relate specifically to energy homeostasis, whether they occur at the subcellular, cellular, organ, or whole organism level. This review operationally refers to this type of metabolism as energy metabolism' or bioenergetics.' Changes in energy metabolism/bioenergetics have been linked to brain aging and a number of neurodegenerative diseases, and research suggests mitochondria may uniquely contribute to this. Interventions that manipulate energy metabolism/bioenergetic function and mitochondria may have therapeutic potential and efforts intended to accomplish this are playing out at basic, translational, and clinical levels. This review follows evolving views of energy metabolism's role in neurodegenerative diseases but especially Alzheimer's disease, with an emphasis on the bench-to-bedside process whose ultimate goal is to develop therapeutic interventions. It further considers challenges encountered during this process, which include linking basic concepts to a medical question at the initial research stage, adapting conceptual knowledge gained to a disease-associated application in the translational stage, extending what has been learned to the clinical arena, and maintaining support for the research at each of these fundamentally linked but functionally distinct stages.
引用
收藏
页码:126 / 135
页数:10
相关论文
共 50 条
  • [41] Cerebrospinal Fluid Biomarkers in Alzheimer's Disease-From Brain Starch to Bench and Bedside
    Pawlowski, Matthias
    Meuth, Sven G.
    Duning, Thomas
    DIAGNOSTICS, 2017, 7 (03)
  • [42] Lutein and cataract: from bench to bedside
    Manayi, Azadeh
    Abdollahi, Mohammad
    Raman, Thiagarajan
    Nabavi, Seyed Fazel
    Habtemariam, Solomon
    Daglia, Maria
    Nabavi, Seyed Mohammad
    CRITICAL REVIEWS IN BIOTECHNOLOGY, 2016, 36 (05) : 829 - 839
  • [43] Imaging technologies from bench to bedside
    Reddy, Ravinder
    Haris, Mohammad
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [44] Molecular, Pathophysiological, and Clinical Aspects of Corticosteroid-Induced Neuropsychiatric Effects: From Bench to Bedside
    Sofia-Avendano-Lopez, Sara
    Rodriguez-Marin, Angela Johanna
    Lara-Castillo, Mateo
    Agresott-Carrillo, Juanita
    Lara-Cortes, Luna Estefania
    Sanchez-Almanzar, Juan Felipe
    Villamil-Cruz, Sophya
    Rojas-Rodriguez, Luis Carlos
    Ariza-Salamanca, Daniel Felipe
    Gaviria-Carrillo, Mariana
    Calderon-Ospina, Carlos Alberto
    Rodriguez-Quintana, Jesus
    BIOMEDICINES, 2024, 12 (09)
  • [45] True or false? Alzheimer's disease is type 3 diabetes: Evidences from bench to bedside
    Peng, Yong
    Yao, Shun-yu
    Chen, Quan
    Jin, Hong
    Du, Miao-qiao
    Xue, Ya-hui
    Liu, Shu
    AGEING RESEARCH REVIEWS, 2024, 99
  • [46] The role of cognitive activity in cognition protection: from Bedside to Bench
    Li, Bin-Yin
    Wang, Ying
    Tang, Hui-dong
    Chen, Sheng-Di
    TRANSLATIONAL NEURODEGENERATION, 2017, 6
  • [47] Editorial: Sirtuins From Bench to Bedside: How Far Are We?
    Thaiparambil, Jose
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [48] Myotonic Dystrophy: From Bench to Bedside
    Johnson, Nicholas E.
    Heatwole, Chad R.
    SEMINARS IN NEUROLOGY, 2012, 32 (03) : 246 - 254
  • [49] The structures of organelles and reticula: Localised bioenergetics and metabolism
    Williams, RJP
    CHEMBIOCHEM, 2001, 2 (09) : 637 - 641
  • [50] Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer's disease from bench to bedside
    Islam, Fahadul
    Nafady, Mohamed H.
    Islam, Md. Rezaul
    Saha, Susmita
    Rashid, Salma
    Akter, Aklima
    Harun-Or-Rashid, Md.
    Akhtar, Muhammad Furqan
    Perveen, Asma
    Md. Ashraf, Ghulam
    Rahman, Md. Habibur
    Hussein Sweilam, Sherouk
    MOLECULAR NEUROBIOLOGY, 2022, 59 (07) : 4384 - 4404